Studies on DNA damage response kinases (ATR and TLK1): targeted therapy for Colorectal Cancer and Glioblastoma

dc.contributor.advisor	Kirubakaran, Sivapriya
dc.contributor.author	Priya, Bhanu
dc.date.accessioned	2024-09-13T08:19:25Z
dc.date.available	2024-09-13T08:19:25Z
dc.date.issued	2023
dc.identifier.citation	Priya, Bhanu (2023). Studies on DNA damage response kinases (ATR and TLK1): targeted therapy for Colorectal Cancer and Glioblastoma. Gandhinagar: Indian Institute of Technology Gandhinagar, 125p. (Acc. No.: T01157).
dc.identifier.uri	https://repository.iitgn.ac.in/handle/123456789/10444
dc.description.statementofresponsibility	by Bhanu Priya
dc.format.extent	xxiii, 125p.: hbk.; 30 cm
dc.language.iso	en_US
dc.publisher	Indian Institute of Technology Gandhinagar
dc.subject	ATR Inhibitors
dc.subject	Tousled Like Kinases (TLK)
dc.subject	DNA Repair
dc.title	Studies on DNA damage response kinases (ATR and TLK1): targeted therapy for Colorectal Cancer and Glioblastoma
dc.type	Thesis
dc.contributor.department	Biological Sciences and Engineering
dc.description.degree	PhD